首页> 外文期刊>Journal of gastroenterology and hepatology >Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.
【24h】

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

机译:与慢性丙型肝炎引起的肝硬化相比,非酒精性脂肪性肝炎引起的肝硬化的临床特征和结局。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIM: Ethnic differences in non-alcoholic steatohepatitis (NASH) are well-documented, but there has been no study on the prognosis of Japanese NASH patients with cirrhosis. Accordingly, we compared cirrhotic NASH with liver cirrhosis caused by chronic hepatitis C (LC-C) to clarify its clinical features and define the risk factors for death. METHODS: A prospective evaluation of the outcomes of NASH patients with severe fibrosis was started in 1990. Data on age- and sex-matched patients with biopsy-proven LC-C were collected retrospectively and used as the control. RESULTS: There were 68 patients with cirrhotic NASH and 69 with LC-C. The Child-Turcotte-Pugh (CTP) class was similar in these two groups. Although the outcome of the NASH group was better than that of the LC-C group, cirrhotic NASH followed a similar course to that of LC-C; that is, complications of cirrhosis developed, including hepatocellular carcinoma (HCC; the 5-year HCC rate was 11.3% for NASH and 30.5% for HCV) and death (the 5-year survival rates were 75.2% and 73.8%, respectively). HCC was the leading cause of death in both groups (NASH, 47%; HCV, 68%). The occurrence of HCC and the CTP class were significant risk factors for mortality in NASH patients according to a multivariate analysis (HCC: hazard ratio [HR] 7.96, 95% confidence interval [CI] 2.45-25.88, CTP class A: HR 0.17, 95% CI 0.06-0.50). CONCLUSION: In conclusion, the present study confirmed that cirrhotic NASH has a similar course to LC-C. The occurrence of HCC was the strongest predictor of mortality in the NASH groups. These findings may be helpful when deciding on therapeutic interventions for NASH and also for the daily management of these patients.
机译:背景与目的:文献记载了非酒精性脂肪性肝炎(NASH)的种族差异,但尚未对日本NASH肝硬化患者的预后进行研究。因此,我们将肝硬化性NASH与慢性丙型肝炎(LC-C)引起的肝硬化进行了比较,以阐明其临床特征并确定死亡的危险因素。方法:1990年开始对NASH严重纤维化患者的结局进行前瞻性评估。回顾性收集年龄和性别匹配的经活检证实为LC-C的患者数据,并将其用作对照。结果:肝硬化NASH患者68例,LC-C患者69例。这两组儿童Child-Turcotte-Pugh(CTP)班级相似。尽管NASH组的疗效优于LC-C组,但肝硬化性NASH的病程与LC-C相似。也就是说,出现了肝硬化并发症,包括肝细胞癌(HCC; NASH的5年HCC率为11.3%,HCV的30.5%)和死亡(5年生存率分别为75.2%和73.8%)。肝癌是两组的主要死亡原因(NASH,47%; HCV,68%)。根据多因素分析(HCC:危险比[HR] 7.96,95%置信区间[CI] 2.45-25.88,CTP A级:HR 0.17,HCC的发生和CTP类是导致NASH患者死亡的重要危险因素。 95%CI 0.06-0.50)。结论:总的来说,本研究证实了肝硬化性NASH与LC-C的病程相似。在NASH组中,HCC的发生是死亡率的最强预测指标。这些结果在决定NASH的治疗干预措施以及这些患者的日常管理时可能会有所帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号